Genpact (NYSE:G) Releases Earnings Results, Beats Estimates By $0.07 EPS

Genpact (NYSE:G) announced its quarterly earnings data on Thursday. The business services provider reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.07, Briefing.com reports. Genpact had a return on equity of 22.71% and a net margin of 11.01%.The firm had revenue of $1.29 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period last year, the business posted $0.85 earnings per share. The company’s revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact updated its FY 2025 guidance to 3.600-3.610 EPS and its Q4 2025 guidance to 0.930-0.940 EPS.

Genpact Price Performance

G stock traded up $6.16 during mid-day trading on Friday, reaching $44.55. 7,040,987 shares of the company’s stock were exchanged, compared to its average volume of 1,853,598. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 1.53. Genpact has a 12-month low of $37.49 and a 12-month high of $56.76. The stock’s 50 day moving average is $41.13 and its 200 day moving average is $43.33. The company has a market cap of $7.76 billion, a price-to-earnings ratio of 14.37, a price-to-earnings-growth ratio of 1.53 and a beta of 0.85.

Genpact Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 23rd. Investors of record on Tuesday, December 9th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, December 9th. This represents a $0.68 dividend on an annualized basis and a yield of 1.5%. Genpact’s dividend payout ratio is presently 22.59%.

Insider Activity at Genpact

In related news, SVP Piyush Mehta sold 76,902 shares of the business’s stock in a transaction on Friday, September 12th. The shares were sold at an average price of $42.58, for a total value of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company’s stock, valued at approximately $5,743,190.40. The trade was a 36.31% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 55,000 shares of the stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the transaction, the chief executive officer directly owned 295,246 shares in the company, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 3.07% of the company’s stock.

Hedge Funds Weigh In On Genpact

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Amundi acquired a new stake in Genpact in the 1st quarter valued at about $58,000. EverSource Wealth Advisors LLC boosted its holdings in shares of Genpact by 79.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,617 shares of the business services provider’s stock worth $115,000 after purchasing an additional 1,156 shares during the last quarter. WealthCollab LLC grew its position in shares of Genpact by 19.6% in the second quarter. WealthCollab LLC now owns 3,167 shares of the business services provider’s stock valued at $139,000 after purchasing an additional 519 shares in the last quarter. Vident Advisory LLC acquired a new stake in shares of Genpact in the second quarter valued at approximately $216,000. Finally, Focus Partners Wealth lifted its position in Genpact by 10.3% during the first quarter. Focus Partners Wealth now owns 5,227 shares of the business services provider’s stock worth $263,000 after buying an additional 488 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

G has been the subject of a number of recent research reports. Citigroup raised shares of Genpact to a “hold” rating in a research report on Thursday, October 23rd. Wall Street Zen cut shares of Genpact from a “buy” rating to a “hold” rating in a report on Friday, September 5th. Needham & Company LLC upped their price target on shares of Genpact from $50.00 to $53.00 and gave the company a “buy” rating in a report on Friday, August 8th. Weiss Ratings reiterated a “hold (c)” rating on shares of Genpact in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. decreased their price objective on Genpact from $55.00 to $50.00 and set a “neutral” rating for the company in a report on Wednesday, August 20th. Three analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $51.13.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.